- Home
- IMVT vs CVBF Comparison
IMVT vs CVBF Comparison
Compare IMVT & CVBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMVT
- CVBF
- Stock Information
- Founded
- IMVT 2018
- CVBF 1974
- Country
- IMVT United States
- CVBF United States
- Employees
- IMVT N/A
- CVBF N/A
- Industry
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- CVBF Major Banks
- Sector
- IMVT Health Care
- CVBF Finance
- Exchange
- IMVT Nasdaq
- CVBF Nasdaq
- Market Cap
- IMVT 2.7B
- CVBF 2.6B
- IPO Year
- IMVT N/A
- CVBF N/A
- Fundamental
- Price
- IMVT $15.24
- CVBF $20.28
- Analyst Decision
- IMVT Buy
- CVBF Buy
- Analyst Count
- IMVT 11
- CVBF 4
- Target Price
- IMVT $35.88
- CVBF $23.25
- AVG Volume (30 Days)
- IMVT 1.2M
- CVBF 661.2K
- Earning Date
- IMVT 08-11-2025
- CVBF 07-23-2025
- Dividend Yield
- IMVT N/A
- CVBF 3.98%
- EPS Growth
- IMVT N/A
- CVBF N/A
- EPS
- IMVT N/A
- CVBF 1.46
- Revenue
- IMVT N/A
- CVBF $507,999,000.00
- Revenue This Year
- IMVT N/A
- CVBF N/A
- Revenue Next Year
- IMVT N/A
- CVBF $8.04
- P/E Ratio
- IMVT N/A
- CVBF $13.76
- Revenue Growth
- IMVT N/A
- CVBF N/A
- 52 Week Low
- IMVT $12.72
- CVBF $16.01
- 52 Week High
- IMVT $34.47
- CVBF $24.58
- Technical
- Relative Strength Index (RSI)
- IMVT 43.58
- CVBF 60.62
- Support Level
- IMVT $14.50
- CVBF $19.08
- Resistance Level
- IMVT $15.52
- CVBF $19.61
- Average True Range (ATR)
- IMVT 0.69
- CVBF 0.42
- MACD
- IMVT -0.06
- CVBF 0.09
- Stochastic Oscillator
- IMVT 41.16
- CVBF 99.11
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.
About CVBF CVB Financial Corporation
CVB Financial Corp is the holding company for Citizens Business Bank. Citizens Business Bank offers banking, lending, and investing services. It provides a full complement of lending products, including commercial, agribusiness, consumer, SBA, real estate, and construction loans, as well as equipment and vehicle leasing. Commercial products include lines of credit and other working capital financing, accounts receivable lending and letters of credit.